Insights into HIV-1 Reverse Transcriptase (RT) Inhibition and Drug Resistance from Thirty Years of Structural Studies
The enzyme reverse transcriptase (RT) plays a central role in the life cycle of human immunodeficiency virus (HIV), and RT has been an important drug target. Elucidations of the RT structures trapping and detailing the enzyme at various functional and conformational states by X-ray crystallography h...
Main Authors: | Abhimanyu K. Singh, Kalyan Das |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/14/5/1027 |
Similar Items
-
Approved HIV reverse transcriptase inhibitors in the past decade
by: Guangdi Li, et al.
Published: (2022-04-01) -
Mathematical Modelling of the Molecular Mechanisms of Interaction of Tenofovir with Emtricitabine against HIV
by: Sara Iannuzzi, et al.
Published: (2021-07-01) -
The “Connection” Between HIV Drug Resistance and RNase H
by: Krista A. Delviks-Frankenberry, et al.
Published: (2010-07-01) -
Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz + tenofovir + emtricitabine for HIV
by: Oliver T. Stirrup, et al.
Published: (2019-10-01) -
Development of HIV Drug Resistance in a Cohort of Adults on First-Line Antiretroviral Therapy in Tanzania during the Stavudine Era
by: Raphael Z. Sangeda, et al.
Published: (2021-11-01)